Bluejay Diagnostics, Inc. (BJDX) vs XORTX Therapeutics Inc. (XRTX)
A side-by-side comparison of Bluejay Diagnostics, Inc. and XORTX Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BJDX
Bluejay Diagnostics, Inc.
$0.81HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XRTX
XORTX Therapeutics Inc.
$1.73HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BJDX vs XRTX
growth of $100 · dividends reinvested · last 5yBJDX -100.0% (-91.5%/yr)XRTX -98.8% (-58.9%/yr)XRTX compounded faster over this window
Log scale — wide-divergence pair
BJDX XRTX
BJDX vs XRTX: by the numbers
- •BJDX is the larger company ($838843 vs $481786 market cap).
Metrics side by side
Valuation
| Metric | BJDX | XRTX |
|---|---|---|
| P/B ratio | 0.09 | 0.09 |
Profitability
| Metric | BJDX | XRTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -77.23% | -68.17% |
| ROIC | -77.55% | -71.43% |
Growth (annualized)
| Metric | BJDX | XRTX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -63.52% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.